These three peptides come up constantly in longevity and mitochondrial-health discussions, but they differ in mechanism and, importantly, in how much human evidence backs them.
Quick answer: Epitalon (epithalon) is a synthetic peptide tied to telomerase and longevity claims that rest largely on limited, older, and preclinical research. MOTS-c is a mitochondrial-derived peptide studied mostly in preclinical models for metabolism and exercise effects, with limited human data. SS-31 (elamipretide) is a mitochondria-targeted peptide that has actually been studied in human clinical trials for mitochondrial and cardiac conditions, with mixed results, giving it the most clinical track record of the three. All are research peptides not approved for general anti-aging use.
Epitalon vs MOTS-c vs SS-31 comparison
| Feature | Epitalon | MOTS-c | SS-31 (elamipretide) |
|---|---|---|---|
| Type | Synthetic tetrapeptide | Mitochondrial-derived peptide | Mitochondria-targeted peptide |
| Studied for | Longevity, telomerase claims | Metabolism, exercise effects | Mitochondrial and cardiac conditions |
| Evidence | Limited, mostly preclinical/older | Limited, mostly preclinical | Human trials, mixed results |
| Approval | Not approved | Not approved | Investigational, studied in trials |
| Clinical maturity | Low | Low | Highest of the three |
What is epitalon and what does the research show?
Epitalon, also spelled epithalon, is a short synthetic peptide that gained attention for longevity claims, often linked to effects on telomerase, the enzyme involved in maintaining telomeres. Much of the supporting research is older, limited, or preclinical, and strong modern human trials are lacking. So while epitalon has an enthusiastic following in longevity circles, the evidence base is thin. It is best viewed as an experimental compound whose anti-aging claims are not established by rigorous human data.
What is MOTS-c?
MOTS-c is a mitochondrial-derived peptide, meaning it is encoded within mitochondrial DNA. Research, largely preclinical, has examined its role in metabolism, insulin sensitivity, and exercise-related effects, generating interest in its potential for metabolic health and physical performance. Human data are limited, so its real-world benefits and safety in people are not well established. MOTS-c is an active research area, but it remains experimental, and claims about its effects should be weighed against the limited human evidence.
From the FormBlends catalog
Epithalon (Epitalon)
The telomerase activator for cellular youth · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View Epithalon (Epitalon) →What is SS-31 (elamipretide)?
SS-31, known in clinical development as elamipretide, is a mitochondria-targeted peptide designed to support mitochondrial function. Unlike the other two, it has been studied in actual human clinical trials for conditions involving mitochondrial dysfunction and certain cardiac problems. Results across those trials have been mixed, but the existence of human trial data gives SS-31 the most clinical track record of the three. It is investigational rather than an approved general-use drug, but it is the furthest along in formal study.
Epitalon vs SS-31: which has more evidence?
SS-31 has more human evidence. It has gone through clinical trials in people, even if the results have been mixed, whereas epitalon's support rests largely on limited and preclinical work. That does not make SS-31 a proven anti-aging treatment; mixed trial results mean its benefits are still being worked out. But on the specific question of which has been more rigorously studied in humans, SS-31 clearly leads. Epitalon and MOTS-c remain earlier-stage in terms of human data.
What this means for you
All three are experimental research peptides, not approved anti-aging treatments, and access to research peptides narrowed after FDA compounding restrictions. SS-31 has the most human study behind it, but even there the evidence is mixed. For healthy aging, well-supported habits, exercise, sleep, nutrition, sun protection, and cardiovascular and metabolic health, do more than any unproven peptide. If you are interested in these compounds, discuss the evidence and risks with a clinician. FormBlends focuses on medically supervised weight management; see our provider comparison tool if weight is part of your goals.
Frequently asked questions
What is the difference between epitalon, MOTS-c, and SS-31?
Epitalon is tied to longevity and telomerase claims, MOTS-c to metabolism, and SS-31 to mitochondrial function with the most human study.
Which has the most evidence?
SS-31 (elamipretide) has the most human clinical data, though results are mixed.
Is epitalon proven to extend lifespan?
No. Its longevity claims rest on limited and preclinical research.
What does MOTS-c do?
Research, mostly preclinical, has examined metabolism and exercise effects; human data are limited.
Is SS-31 approved?
It is investigational, studied in human trials, not an approved general-use drug.
Are these peptides safe?
Safety for general anti-aging use is not established; SS-31 has the most human safety data, but it is mixed.
Should I use any of these?
Only with a clinician, given the limited evidence and narrowed access after FDA restrictions.
Sources
- PubMed listings for elamipretide (SS-31) trials: https://pubmed.ncbi.nlm.nih.gov/
- PubMed listings for MOTS-c and epitalon research: https://pubmed.ncbi.nlm.nih.gov/
Related guides
- NAD+ vs Epithalon vs MOTS-c for Longevity: Three Anti-Aging Strategies Compared
- Epithalon vs NAD+ Injections: Anti-Aging Approaches
- BPC-157 vs GHK-Cu: Healing vs Anti-Aging Peptides
- Top 15 Anti-Aging Peptides Ranked by Evidence
- Thymosin Alpha-1 vs LL-37 vs KPV: Three Immune Peptides — Different Mechanisms, Different Uses
- Best Anti-Aging Peptide Clinics 2026
Ready when you are
Epithalon (Epitalon)
The telomerase activator for cellular youth · From $199/mo · compounded by a licensed 503A pharmacy, dispensed only after provider review.
View Epithalon (Epitalon) →